Market Cap : 76.64 B | Enterprise Value : 66.98 B | PE Ratio : 24.16 | PB Ratio : 6.42 |
---|
NAS:VRTX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:VRTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Vertex Pharmaceuticals's Average Total Inventories for the three months ended in Jun. 2022 was $353 Mil. Vertex Pharmaceuticals's Cost of Goods Sold for the three months ended in Jun. 2022 was $262 Mil. Hence, Vertex Pharmaceuticals's Days Inventory for the three months ended in Jun. 2022 was 123.14.
The historical rank and industry rank for Vertex Pharmaceuticals's Days Inventory or its related term are showing as below:
During the past 13 years, Vertex Pharmaceuticals's highest Days Inventory was 134.64. The lowest was 62.49. And the median was 114.01.
VRTX's Days Inventory is ranked better thanVertex Pharmaceuticals's Days Inventory declined from Jun. 2021 (124.16) to Jun. 2022 (123.14).
Inventory Turnover measures how fast the company turns over its inventory within a year. Vertex Pharmaceuticals's Inventory Turnover for the three months ended in Jun. 2022 was 0.74.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Vertex Pharmaceuticals's Inventory-to-Revenue for the three months ended in Jun. 2022 was 0.16.
The historical data trend for Vertex Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Vertex Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Vertex Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vertex Pharmaceuticals's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Vertex Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as
Days Inventory (A: Dec. 2021 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2020 ) | + | Total Inventories (A: Dec. 2021 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2021 ) | * | Days in Period |
= | ( (280.8 | + | 353.1) | / | 2 ) | / | 904.2 | * | 365 |
= | 316.95 | / | 904.2 | * | 365 | ||||
= | 127.94 |
Vertex Pharmaceuticals's Days Inventory for the quarter that ended in Jun. 2022 is calculated as:
Days Inventory (Q: Jun. 2022 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Mar. 2022 ) | + | Total Inventories (Q: Jun. 2022 )) | / | count ) | / | Cost of Goods Sold (Q: Jun. 2022 ) | * | Days in Period |
= | ( (338.9 | + | 367.7) | / | 2 ) | / | 261.8 | * | 365 / 4 |
= | 353.3 | / | 261.8 | * | 365 / 4 | ||||
= | 123.14 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vertex Pharmaceuticals's Inventory Turnover for the three months ended in Jun. 2022 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 261.8 | / | 353.3 | |
= | 0.74 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vertex Pharmaceuticals's Inventory to Revenue for the three months ended in Jun. 2022 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 353.3 | / | 2196.2 | |
= | 0.16 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Vertex Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Upadhyay Suketu | director | 345 E. MAIN STREET WARSAW IN 46580 |
Garber Alan M | director | 3355 MILTON COURT MOUNTAIN VIEW CA 94040 |
Kearney Terrence C | director | IN CARE OF HOSPIRA, INC. 275 NORTH FIELD DRIVE LAKE FOREST IL 60045 |
Carney Lloyd | director | C/O MICROMUSE INC 139 TOWNSEND ST SAN FRANCISCO CA 94107 |
Mckenzie Diana | director | METLIFE 200 PARK AVENUE NEW YORK NY 10166 |
Bhatia Sangeeta N. | director | C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210 |
Lee Yuchun | director | 170 TRACER LA. WALTHAM MA 02451 |
Ambrose Kristen | officer: SVP & Chief Accounting Officer | C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 |
Mcglynn Margaret G | director | C/O MERCK & CO INC ONE MERCK DRIVE PO BOX 100 WHITEHOUSE STATION NJ 08889-0100 |
Liu Joy | officer: SVP, General Counsel | C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 |
Tatsis Ourania | officer: EVP, Chief Reg. & Quality Off. | C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210 |
Bozic Carmen | officer: EVP and CMO | C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210 |
Wagner Charles F Jr | officer: EVP & Chief Financial Officer | C/O MILLIPORE CORP BILLERICA MA 01820 |
Arbuckle Stuart A | officer: EVP, COO | VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 |
Kewalramani Reshma | director, officer: CEO & President | C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210 |
Other Sources
By Zacks 2022-03-24
By Zacks 2022-03-30
By Zacks 2022-03-31
By Zacks 2022-03-29
By Zacks 2022-03-28
By Zacks 2022-03-30
By Zacks 2022-03-28
By Zacks 2022-03-29
By Zacks 2022-03-24
By Zacks 2022-03-28
By tipranks.com 2022-04-01
By Zacks 2022-03-25
By Zacks 2022-03-30
By Zacks 2022-04-01